Lithium and Acetate for Canavan Disease - Related Studies

Lithium and Acetate for Canavan Disease

This study is not yet open for participant recruitment.

Study NCT00657748. Last updated on April 11, 2008. Information provided by Assistance Publique - Hôpitaux de Paris

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Canavan Disease
		Infantile
		Deficiency Disease
		Aspartoacylase
		Leukodystrophy, Spongiform

2	Additional conditions recognized in this trial
		Deficiency Diseases

3	More general conditions related to this trial
		Demyelinating Diseases
		Genetic Diseases, Inborn
		Hereditary Central Nervous System Demyelinating Diseases
		Heredodegenerative Disorders, Nervous System
		Malnutrition
		Nervous System Diseases
		Neurodegenerative Diseases
		Nutrition Disorders

4	Additional drug interventions recognized in this trial
		Lithium
		Lithium Carbonate
		Triacetin

5	More general drug interventions related to this trial
		Anti-Infective Agents
		Antidepressive Agents
		Antifungal Agents
		Antimanic Agents
		Antipsychotic Agents
		Central Nervous System Agents
		Central Nervous System Depressants
		Enzyme Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Psychotropic Drugs
		Therapeutic Uses
		Tranquilizing Agents

6	Sponsors listed in this trial
		Assistance Publique - Hôpitaux de Paris
		ELA foundation (European Leukodystrophy Association)